Moderate Volatility Stocks
These carefully selected stocks offer the perfect balance between growth potential and stability. Our professional analysts have handpicked companies that can help you participate in market gains while potentially reducing downside risk during turbulent times.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Unlock all stocks by downloading the app for FREE.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
These moderate volatility stocks represent a balanced approach to investing, offering a middle ground between aggressive growth and defensive stability. They're selected to help you capture upside potential while providing some cushion during market downturns—ideal for investors seeking measured risk.
What You Need to Know
Moderate volatility stocks typically fluctuate less dramatically than the broader market while still offering meaningful growth potential. They tend to be established companies with strong fundamentals across diverse sectors including technology, finance, retail, and healthcare.
Why These Stocks
Each company in this collection was selected for its proven business model, market leadership, and ability to navigate changing economic conditions. These stocks represent a sweet spot for many investors—offering enough movement for potential gains without the extreme swings of highly volatile assets.
Group Performance Snapshot
Stocks Rated Buy by Analysts
7 of 7 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 1.1% return last month.
Why You'll Want to Watch These Stocks
The Perfect Balance
These stocks offer the sweet spot between exciting growth and reassuring stability—making them ideal for investors who want opportunity without excessive market stress.
Built-In Protection
When markets get rocky, moderate volatility stocks typically show more resilience than their high-flying counterparts, potentially helping protect your portfolio during downturns.
Market Leaders Only
This collection features established powerhouses like Microsoft, Apple, and Visa—companies with proven track records of navigating market cycles while delivering long-term value.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.